Hyperin Controls the Development and Therapy of Gastric Cancer via Regulating Wnt/β-Catenin Signaling

References

• Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet (London, England). 2016;388(10060):2654–2664. doi:10.1016/S0140-6736(16)30354-3
   PubMed Web of Science ®Google Scholar
• Cai H, Ye F, Michel A, et al. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia. Int J Epidemiol. 2016;45(3):774–781. doi:10.1093/ije/dyw07827170766
   PubMed Web of Science ®Google Scholar
• Wang SM, Zheng RS, Zhang SW, et al. [Epidemiological characteristics of gastric cancer in China, 2015]. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. 2019;40(12):1517–1521. Chinese.32062908
   PubMedGoogle Scholar
• Zhu Z, Wu P, Du N, et al. Surgical choice of proximal gastric cancer in China: a retrospective study of a 30-year experience from a single center in China. Expert Rev Gastroenterol Hepatol. 2019;13(11):1123–1128. doi:10.1080/17474124.2019.168981631687853
   PubMed Web of Science ®Google Scholar
• Oncology The Lancet. Rethinking traditional Chinese medicines for cancer. Lancet Oncol. 2015;16(15):1439. doi:10.1016/S1470-2045(15)00406-426545833
   PubMed Web of Science ®Google Scholar
• Xue T, Roy R. Studying traditional Chinese medicine. Science (New York, NY). 2003;300(5620):740–741. doi:10.1126/science.300.5620.740
   Google Scholar
• Yang J, Zhu L, Wu Z, Wang Y. Chinese herbal medicines for induction of remission in advanced or late gastric cancer. Cochrane Database System Rev. 2013;(4):CD005096.23633324
   PubMed Web of Science ®Google Scholar
• Zhou Y, Xu Q, Shang J, Lu L, Chen G. Crocin inhibits the migration, invasion, and epithelial-mesenchymal transition of gastric cancer cells via miR-320/KLF5/HIF-1α signaling. J Cell Physiol. 2019;234(10):17876–17885. doi:10.1002/jcp.2841830851060
   PubMed Web of Science ®Google Scholar
• Wang LM, Zhang MY, Zhu QS, Lu CF, Bai X. Hyperin enhances the sensitivity of HCT8/VCR colon cancer cell line to vincristine by down-regulating P-glycoprotein. Clin Lab. 2018;64(3):269–275. doi:10.7754/Clin.Lab.2017.17092329739100
   PubMed Web of Science ®Google Scholar
• Li JP, Liao XH, Xiang Y, et al. Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1/S phase arrest. Gene. 2018;679:232–240. doi:10.1016/j.gene.2018.09.01130201337
   PubMed Web of Science ®Google Scholar
• Lü P. Inhibitory effects of hyperoside on lung cancer by inducing apoptosis and suppressing inflammatory response via caspase-3 and NF-κB signaling pathway. Biomed Pharmacother. 2016;82:216–225. doi:10.1016/j.biopha.2016.05.00627470358
   PubMed Web of Science ®Google Scholar
• Fu T, Wang L, Jin XN, Sui HJ, Liu Z, Jin Y. Hyperoside induces both autophagy and apoptosis in non-small cell lung cancer cells in vitro. Acta Pharmacol Sin. 2016;37(4):505–518. doi:10.1038/aps.2015.14826948085
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhao P, Xu H. Hyperoside exhibits anticancer activity in non‑small cell lung cancer cells with T790M mutations by upregulating FoxO1 via CCAT1. Oncol Rep. 2020;43(2):617–624.31894285
   PubMed Web of Science ®Google Scholar
• Yang FQ, Liu M, Li W, Che JP, Wang GC, Zheng JH. Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA‑21. Mol Med Rep. 2015;11(2):1085–1092. doi:10.3892/mmr.2014.281325354548
   PubMed Web of Science ®Google Scholar
• Geng M, Wang JH, Chen HY, Yang XB, Huang ZM. [Effects of hyperin on the cccDNA of duck hepatitis B virus and its immunological regulation]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 2009;44(12):1440–1444. Chinese.21351483
   PubMedGoogle Scholar
• Yang Y, Li Z, Chen G, et al. GSK3β regulates ameloblast differentiation via Wnt and TGF-β pathways. J Cell Physiol. 2018;233(7):5322–5333. doi:10.1002/jcp.2634429215720
   PubMed Web of Science ®Google Scholar
• Lyros O, Lamprecht AK, Nie L, et al. Dickkopf-1 (DKK1) promotes tumor growth via Akt-phosphorylation and independently of Wnt-axis in Barrett’s associated esophageal adenocarcinoma. Am J Cancer Res. 2019;9(2):330–346.30906632
   PubMed Web of Science ®Google Scholar
• Twaroski K, Mallanna SK, Jing R, DiFurio F, Urick A, Duncan SA. FGF2 mediates hepatic progenitor cell formation during human pluripotent stem cell differentiation by inducing the WNT antagonist NKD1. Genes Dev. 2015;29(23):2463–2474. doi:10.1101/gad.268961.11526637527
   PubMed Web of Science ®Google Scholar
• Onyido EK, Sweeney E, Nateri AS. Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches. Mol Cancer. 2016;15(1):56.27590724
   PubMed Web of Science ®Google Scholar
• Masuda M, Sawa M, Yamada T. Therapeutic targets in the Wnt signaling pathway: feasibility of targeting TNIK in colorectal cancer. Pharmacol Ther. 2015;156:1–9. doi:10.1016/j.pharmthera.2015.10.00926542362
   PubMed Web of Science ®Google Scholar
• Parekh HS, Liu G, Wei MQ. A new dawn for the use of traditional Chinese medicine in cancer therapy. Mol Cancer. 2009;8:21. doi:10.1186/1476-4598-8-2119298677
   PubMed Web of Science ®Google Scholar
• Efferth T, Li PC, Konkimalla VS, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 2007;13(8):353–361. doi:10.1016/j.molmed.2007.07.00117644431
   PubMed Web of Science ®Google Scholar
• Qiu J, Zhang T, Zhu X, et al. Hyperoside induces breast cancer cells apoptosis via ROS-mediated NF-κB signaling pathway. Int J Mol Sci. 2019;21(1):131. doi:10.3390/ijms21010131
   PubMed Web of Science ®Google Scholar
• Liu YH, Liu GH, Mei JJ, Wang J. The preventive effects of hyperoside on lung cancer in vitro by inducing apoptosis and inhibiting proliferation through Caspase-3 and P53 signaling pathway. Biomed Pharmacother. 2016;83:381–391. doi:10.1016/j.biopha.2016.06.03527419887
   PubMed Web of Science ®Google Scholar
• Wang B, Tian T, Kalland KH, Ke X, Qu Y. Targeting Wnt/β-catenin signaling for cancer immunotherapy. Trends Pharmacol Sci. 2018;39(7):648–658. doi:10.1016/j.tips.2018.03.00829678298
   PubMed Web of Science ®Google Scholar
• Stewart DJ. Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst. 2014;106(1):djt356. doi:10.1093/jnci/djt35624309006
   PubMedGoogle Scholar
• Galluzzi L, Spranger S, Fuchs E, López-Soto A. WNT signaling in cancer immunosurveillance. Trends Cell Biol. 2019;29(1):44–65. doi:10.1016/j.tcb.2018.08.00530220580
   PubMed Web of Science ®Google Scholar
• Wang T, Wu H, Liu S, et al. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance. Cancer Lett. 2018;430:11–24. doi:10.1016/j.canlet.2018.05.00329746925
   PubMed Web of Science ®Google Scholar
• Yu Y, Yan W, Liu X, et al. DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling. Am J Cancer Res. 2014;4(6):710–724.25520862
   PubMed Web of Science ®Google Scholar